Dong-A Pharm to introduce Qvar under exclusive licensing agreement with 3M

Published: 2003-01-21 06:56:00

Updated: 2003-01-21 06:56:00

Dong-A Pharm said on January 13 that it singed with 3M of the United States an agreement for the exclusive marketing in Korea of Qvar (beclomethasone dipropionate ), a metered dose inhaler (MDI).

Using an innovative DDS technology and novel device mechanism, Qvar have the two types of inhalers - Qvar autohaler as the first breath actuated metered dose inhaler (BAMDI) and currently marketed ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.